Skip to main content

fda_recall · device_recall · high

Medtronic Neuromodulation — Class II recall: Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for…

Event date
2023-01-18 00:00:00Z
Observed
2026-07-16 23:20:09Z
Source ID
Z-0911-2023
Payload hash
15e5b1d47463f45828c6603a…

Summary

Software anomalies, CP App messages: "Too Many Device Found", "Unexpected Device Error Code 1502", and "System Update Needed, Service Code 303" Status: Ongoing.

Entities

View source record ↗

Frequently asked questions

Has Medtronic Neuromodulation had other FDA enforcement actions?
Yes. Argus HQ has recorded 36 total FDA actions tied to Medtronic Neuromodulation: 0 warning letters, 36 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?
This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2023-01-18; Argus observed and indexed it on 2026-07-16.
Where can I verify this record directly with FDA?
The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA
Argus HQ Research (2023). Medtronic Neuromodulation — Class II recall: Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-medtronic-neuromodulation-z-0911-2023
MLA
"Medtronic Neuromodulation — Class II recall: Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for…." Argus HQ Research, Digital Empire Holdings LLC, 2023, argushq.ai/events/fda-recall-medtronic-neuromodulation-z-0911-2023.
Chicago
Argus HQ Research. "Medtronic Neuromodulation — Class II recall: Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for…." Digital Empire Holdings LLC. Accessed July 23, 2026. https://argushq.ai/events/fda-recall-medtronic-neuromodulation-z-0911-2023.
BibTeX
@misc{argushq_argushq_ai_events_fda_recall_medtronic_neuromodulation_z_0911_2023_2023,
  title = {Medtronic Neuromodulation — Class II recall: Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for…},
  author = {{Argus HQ Research}},
  year = {2023},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-medtronic-neuromodulation-z-0911-2023},
  note = {Accessed: July 23, 2026}
}

Informational only. Not legal, financial, or medical advice.

Medtronic Neuromodulation — Class II recall: Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for… · Argus HQ